Institutional investors hold a majority ownership of AMGN through the 82.24% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ASSENAGON ASSET MANAGEMENT SA (G... Bought 91.3 Thousand shares of Amgen
NORDEA INVESTMENT MANAGEMENT AB ... Bought 57.7 Thousand shares of Amgen
BMO ASSET MANAGEMENT, INC. Bought 31.9 Thousand shares of Amgen